Schedule 13G ownership disclosure
PLUS THERAPEUTICS INC
Security class unavailable · CUSIP: 72941H400
Event date: 2022-01-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-22-000666
- Form type
- SC 13G
- Filer
- PLUS THERAPEUTICS, INC.
- CIK
- CIK 1095981
- Filed
- Feb 04, 2022
- Reporting period
- Jan 28, 2022
- Description
- Schedule 13G beneficial ownership